Clinical and regulatory intelligence for Hepatitis D with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Assets: 1

Relevant assets

Hepatitis →

Relevant companies

Roche →

Recent signals(2)

StrategyJuly 14, 2026

Roche launches first fully automated cobas HDV test for Hepatitis D diagnosis

Roche has introduced the cobas HDV test, the first fully automated diagnostic solution for Hepatitis D Virus.

CompetitiveJuly 14, 2026

Roche Launches First Fully Automated HDV Test to Enhance Diagnosis and Monitoring

Roche has introduced the cobas HDV test, the first fully automated diagnostic solution for Hepatitis D Virus, enhancing diagnosis and treatment monitoring.

Upcoming catalysts

No catalysts indexed for this entity yet.

Therapeutic areas

Hepatitis D →

Infectious Diseases →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.